Scarica l'app Stockscreener
0.4497
2.22%
-0.0102
Dopo l'orario di chiusura:
.46
0.0103
+2.29%
Precedente Chiudi:
$0.4599
Aprire:
$0.46
Volume 24 ore:
4.47M
Relative Volume:
0.15
Capitalizzazione di mercato:
$44.64M
Reddito:
-
Utile/perdita netta:
$-12.89M
Rapporto P/E:
-0.1777
EPS:
-2.53
Flusso di cassa netto:
$-11.95M
1 W Prestazione:
-8.19%
1M Prestazione:
-39.16%
6M Prestazione:
+48.81%
1 anno Prestazione:
-68.66%
Intervallo 1D:
$0.4428
$0.4869
Intervallo di 1 settimana:
$0.385
$0.4913
Portata 52W:
$0.1634
$2.3099
Plus Therapeutics Inc Stock (PSTV) Company Profile
Nome
Plus Therapeutics Inc
Settore
Industria
Telefono
737.255.7194
Indirizzo
4200 MARATHON BLVD., AUSTIN, TX
Confronta PSTV con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PSTV
Plus Therapeutics Inc
|
0.4497 | 42.43M | 0 | -12.89M | -11.95M | -2.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Plus Therapeutics Inc Stock (PSTV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-17 | Iniziato | D. Boral Capital | Buy |
| 2021-01-25 | Iniziato | Ladenburg Thalmann | Buy |
| 2020-10-16 | Iniziato | Maxim Group | Buy |
Plus Therapeutics Inc Borsa (PSTV) Ultime notizie
Plus Therapeutics shares rise 4.68% intraday after announcing participation in H.C. Wainwright 27th Annual Global Investment Conference. - AInvest
Using data tools to time your Plus Therapeutics Inc. exitJuly 2025 Spike Watch & Precise Swing Trade Entry Alerts - Newser
Plus Therapeutics stock rating upgraded to Buy by D. Boral Capital - Investing.com
This BorgWarner Analyst Turns Bullish; Here Are Top 3 Upgrades For Wednesday - Benzinga
Market reaction to Plus Therapeutics Inc.’s recent news2025 Sector Review & Daily Chart Pattern Signal Reports - Newser
Can Plus Therapeutics Inc. hit a new high this month2025 Biggest Moves & Free High Accuracy Swing Entry Alerts - Newser
Custom watchlist performance reports with Plus Therapeutics Inc2025 Historical Comparison & Weekly Watchlist for Hot Stocks - Newser
Is a relief rally coming for Plus Therapeutics Inc. holdersEarnings Performance Report & Weekly High Return Stock Forecasts - Newser
Plus Therapeutics Inc. stock momentum explainedMarket Weekly Review & Expert Curated Trade Ideas - Newser
Plus Therapeutics Inc. stock trendline breakdownEarnings Summary Report & Weekly High Potential Stock Alerts - Newser
How to read the order book for Plus Therapeutics Inc.2025 Big Picture & Technical Buy Zone Confirmations - Newser
Will Plus Therapeutics Inc. stock hit new highs in YEARWeekly Profit Recap & Capital Protection Trading Alerts - khodrobank.com
Can machine learning forecast Plus Therapeutics Inc. recoveryJuly 2025 Big Picture & Low Risk High Win Rate Stock Picks - Newser
Building trade automation scripts for Plus Therapeutics Inc.2025 Year in Review & Real-Time Stock Price Movement Reports - Newser
What Fibonacci levels say about Plus Therapeutics Inc. rebound2025 AllTime Highs & Free Reliable Trade Execution Plans - Newser
What technical models suggest about Plus Therapeutics Inc.’s comebackWeekly Stock Analysis & Free Community Supported Trade Ideas - Newser
What moving averages say about Plus Therapeutics Inc.2025 Geopolitical Influence & Weekly Top Performers Watchlists - Newser
Live market analysis of Plus Therapeutics Inc.July 2025 Review & Daily Chart Pattern Signals - Newser
How to forecast Plus Therapeutics Inc. trends using time seriesJuly 2025 Review & Real-Time Market Sentiment Alerts - Newser
Plus Therapeutics Inc. recovery potential after sell off2025 Dividend Review & Community Shared Stock Ideas - Newser
Plus Therapeutics, Inc. to Participate in H.C. Wainwright 27th Annual Global Investment Conference 2025 - Quiver Quantitative
Plus Therapeutics to Participate in Fireside Chat at the H.C. Wainwright 27th Annual Global Investment Conference - The Manila Times
CNS Cancer Drug Developer Plus Therapeutics Featured at Major H.C. Wainwright Investment Conference - Stock Titan
Ranking Plus Therapeutics Inc. among high performing stocks via toolsJuly 2025 Macro Moves & Real-Time Volume Triggers - Newser
Is Plus Therapeutics Inc. building a consolidation baseJuly 2025 EndofMonth & Comprehensive Market Scan Insights - Newser
What is Plus Therapeutics Inc. s revenue forecastTrade Performance Summary & High Accuracy Swing Trade Signals - khodrobank.com
Custom watchlist performance reports with Plus Therapeutics Inc.2025 Technical Overview & Safe Capital Growth Tips - Newser
Guidance Update: Is now the right time to enter Plus Therapeutics Inc.Weekly Earnings Recap & Risk Managed Trade Strategies - khodrobank.com
Tick level data insight on Plus Therapeutics Inc. volatilityPortfolio Gains Summary & Daily Chart Pattern Signals - Newser
Is Plus Therapeutics Inc. stock reversal real or fakeWeekly Profit Summary & Fast Exit and Entry Strategy Plans - Newser
What is the long term forecast for Plus Therapeutics Inc. stock2025 Winners & Losers & Community Verified Trade Alerts - خودرو بانک
Multi asset correlation models including Plus Therapeutics Inc.2025 Bull vs Bear & Real-Time Volume Analysis - Newser
What is Plus Therapeutics Inc.’s valuation compared to sectorMarket Trend Report & Precise Entry and Exit Recommendations - khodrobank.com
Visualizing Plus Therapeutics Inc. stock with heatmapsCPI Data & Community Consensus Stock Picks - Newser
Will Plus Therapeutics Inc. bounce back from current supportEarnings Risk Summary & Weekly Top Gainers Alerts - Newser
How to integrate Plus Therapeutics Inc. into portfolio analysis toolsMarket Movement Recap & Step-by-Step Trade Execution Guides - Newser
Quarterly Earnings: What is Plus Therapeutics Inc.’s valuation compared to sectorRisk Management & Growth Focused Entry Reports - khodrobank.com
Order Book Volume Tilts Bullish on Plus Therapeutics Inc.2025 Short Interest & Low Risk High Win Rate Stock Picks - beatles.ru
Aug Technicals: What is the long term forecast for Plus Therapeutics Inc. stockGold Moves & Free Accurate Trade Setup Notifications - خودرو بانک
Will Plus Therapeutics Inc. rebound enough to break evenMarket Growth Report & Daily Market Momentum Tracking - Newser
What’s the recovery path for long term holders of Plus Therapeutics Inc.Quarterly Portfolio Summary & Weekly Setup with High ROI Potential - Newser
Evaluating Plus Therapeutics Inc. with trendline analysisJuly 2025 Catalysts & Long-Term Capital Growth Strategies - Newser
What data driven models say about Plus Therapeutics Inc.’s futureTrade Exit Summary & Stepwise Trade Signal Implementation - Newser
Backtesting results for Plus Therapeutics Inc. trading strategiesTrade Analysis Report & Proven Capital Preservation Methods - Newser
Using portfolio simulators with Plus Therapeutics Inc. includedMarket Growth Review & Free Reliable Trade Execution Plans - Newser
Plus Therapeutics Inc Azioni (PSTV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):